20 March 2020 | GENEVA: As the world comes together to tackle the COVID-19 pandemic, it is important to ensure that essential health services and operations are continued to protect the lives of people with TB and other diseases or health conditions. Health services, including national programmes to combat TB, need to be actively engaged in ensuring an effective and rapid response to COVID-19 while ensuring that TB services are maintained.

WHO advocacy and communications package to support awareness building and drive action across all levels, in the lead up to and on World TB Day.

The World Health Organization issues a Rapid Communication announcing a number of updates to its latest guidance on TB preventive treatment.

07 February 2020 | GENEVA - Member States during the 146th session of the World Health Organization (WHO) Executive Board, reviewed a  progress report on the implementation of the End TB Strategy and put forward a resolution to the World Health Assembly adopting a new global strategy for tuberculosis (TB) research and innovation.

The World Health Organization (WHO) Global TB Program, in close collaboration with the Global Fund to Fight AIDS, Tuberculosis and Malaria, the United States Agency for International Development (USAID) and the Global Drug Facility of the Stop TB Partnership have updated the Frequently Asked Questions (FAQs) document on WHO’s Rapid Communication: Key changes to the treatment of drug-resistant tuberculosis.

Two new reports of the World Health Organization reveal a weak pipeline for antibiotic agents.

13 January 2020 | GENEVA - Significant improvements to the diagnosis of tuberculosis (TB) and rifampicin resistance in adults and children are expected, following key updates on new molecular assays, announced by the World Health Organization (WHO) in a Rapid Communication released today.

The World Health Organization (WHO) Global TB Program released a newsletter highlighting the overall progress in the global TB response in 2019. The Global TB Report 2019 is now available in app form.

WHO releases a Rapid Communication in advance of the updated guidelines for the treatment of drug-resistant TB expected in 2020.

29 November 2019 | Hanoi: The pace of progress in addressing TB in children and adolescents remains slow, especially in ensuring access to TB prevention and care. To address this critical issue, WHO convened a global consultation on 26-28 November in Hanoi, Viet Nam, bringing together over 100 stakeholders from across 12 countries including national TB programmes, paediatric societies, technical and financial partners as well as civil society. The consultation was hosted by the Viet Nam Government.